FMP

FMP

Enter

ZSAN - Zosano Pharma Corporation

Profile of Zosano Pharma Corporation(ZSAN), Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeu

About

ceo

Steven Lo

sector

Healthcare

industry

Biotechnology

website

https://www.zosanopharma.com

exchange

NASDAQ

Description

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

CIK

0001587221

ISIN

US98979H2022

CUSIP

98979H202

Address

34790 Ardentech Ct

Phone

15107451200

Country

US

Employee

40

IPO Date

Jan 27, 2015

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep